Press release
Cancer Supportive Care Drugs Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis
Cancer Supportive Care Drugs
What Is the Current Cancer Supportive Care Drugs Market Size and Its Estimated Growth Rate?
The cancer supportive care drugs market has grown steadily in recent years. It will increase from $20.83 billion in 2024 to $21.85 billion in 2025, at a CAGR of 4.9%. The growth is driven by the aging population, increased chemotherapy use, growing demand for antiemetics, a preference for online pharmacies, awareness of supportive care, the rise of personalized medicine, and an emphasis on palliative care.
The cancer supportive care drugs market is expected to grow to $26.1 billion by 2029, at a CAGR of 4.5%. This growth is driven by awareness of treatment side effects, the rise of breast cancer cases, specific medication plans, and a better supply chain in the pharmaceutical sector. Trends include targeted therapies, biobehavioral interventions, survivorship care plans, and pain management advancements.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15749
How Are Emerging Segments Shaping the Cancer Supportive Care Drugs Market Landscape?
The cancer supportive care drugs market covered in this report is segmented -
1) By Type: Erythropoiesis Stimulating Agents, Granulocyte Colony Stimulating Factors, Antiemetics, Bisphosphonates, Opioids, Nonsteroidal Anti Inflammatory Drugs, Other Types
2) By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Stomach Cancer, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics, Other Channels
Subsegments:
1) By Erythropoiesis Stimulating Agents: Epoetin Alfa, Darbepoetin Alfa, Methoxy Polyethylene Glycol-Epoetin Beta
2) By Granulocyte Colony Stimulating Factors: Filgrastim, Pegfilgrastim, Lenograstim
3) By Antiemetics: 5-HT3 Receptor Antagonists, NK1 Receptor Antagonists, Corticosteroids
4) By Bisphosphonates: Zoledronic Acid, Pamidronate, Ibandronate
5) By Opioids: Morphine, Fentanyl, Oxycodone
6) By Nonsteroidal Anti Inflammatory Drugs (NSAIDs): Ibuprofen, Diclofenac, Celecoxib
7) By Other Types: Steroids, Anxiolytics, Appetite Stimulants
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15749&type=smp
Which Growth Factors Are Influencing Cancer Supportive Care Drugs Market Expansion?
The improved survival rate for cancer patients is expected to drive the growth of the cancer supportive care drugs market. Survival rates for cancer patients are rising due to early detection, better treatments, and quality healTH*Care access. Supportive care drugs, which help manage side effects like pain and nausea, are essential for improving patient outcomes and enabling them to complete their treatments. The National Cancer Institute projected that the number of cancer survivors in the U.S. will increase by 24.4% by 2032. Therefore, the improved survival rates are contributing to the growth of the cancer supportive care drugs market.
Who Are the Dominant Players Across Different Cancer Supportive Care Drugs Market Segments?
Major companies operating in the cancer supportive care drugs market are Pfizer Inc., Johnson & Johnson, Merck, AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Novartis AG, F Hoffmann-La Roche Ltd., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Eisai Co. Ltd., Incyte Corporation, Exelixis Inc., Fagron Group, Heron Therapeutics Inc., Athenex Inc., Acrotech Biopharma LLC
What Are the Latest Developing Trends in the Cancer Supportive Care Drugs Market?
Companies in the cancer support care drugs market are developing combination therapies to address the complexities of cancer treatment. In November 2023, Merck received FDA approval for KEYTRUDA, an anti-PD-1 therapy, combined with gemcitabine and cisplatin for treating advanced biliary tract cancer. This combination therapy showed promising results, offering a new treatment option for challenging cases of this cancer.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/cancer-supportive-care-drugs-global-market-report
Which Geographic Regions Are Expected to Dominate the Cancer Supportive Care Drugs Market in the Coming Years?
North America was the largest region in the cancer supportive care drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer supportive care drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Cancer Supportive Care Drugs Market?
2. What is the CAGR expected in the Cancer Supportive Care Drugs Market?
3. What Are the Key Innovations Transforming the Cancer Supportive Care Drugs Industry?
4. Which Region Is Leading the Cancer Supportive Care Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Supportive Care Drugs Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis here
News-ID: 4035311 • Views: …
More Releases from The Business Research Company
Strong Growth Ahead: Elder Care Assistive Robots Market Size To Grow At Arecord …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How Big Is the Elder Care Assistive Robots Market Size Expected to Be by 2034?
The market size for elder care assistive robots has experienced a fast-paced growth over the recent past. The expectation is for it to rise from a recorded $2.98 billion in 2024 to a projected $3.49 billion come 2025, a…
Emerging Trends Influencing The Growth Of The Distillers Dried Grains With Solub …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How Big Is the Distillers Dried Grains With Solubles Market Size Expected to Be by 2034?
In recent years, the market for distillers dried grains with solubles has witnessed robust growth. An escalation from $12.45 billion in 2024 to $13.39 billion in 2025 is anticipated, reflecting a compound annual growth rate (CAGR) of 7.6%.…
Global Digital Insomnia Therapeutics Market Analysis 2025-2030: Growth Drivers, …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How Big Is the Digital Insomnia Therapeutics Market Size Expected to Be by 2034?
Over the past few years, the digital insomnia therapeutics market has experienced significant expansion. The size of this market is projected to increase from $3.27 billion in 2024 to $3.49 billion in 2025, showcasing a compound annual growth rate (CAGR)…
Strong Growth Ahead: Dengue Treatment Market Size To Grow At Arecord 11.6% Cagr …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How Big Is the Dengue Treatment Market Size Expected to Be by 2034?
The market for dengue treatment has experienced rapid expansion in the last few years. The market size is expected to scale up from $2.10 billion in 2024 to $2.35 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%.…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
